Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Just when we thought the GLP-1 revolution had peaked, Eli Lilly released the first Phase 3 data for Retatrutideand the numbers are frankly staggering
2001, 280: H812-H820
Over 29 days of treatment, the peptide inhibited pulmonary artery muscularization (the thickening and stiffening of pulmonary arteries that drives this condition), prevented right heart hypertrophy (the enlargement of the right ventricle that occurs when it has to pump against increased resistance), and significantly decreased mortality
Multiple patients specifically note having minimal or no side effects, which aligns with the broader tirzepatide experience
Its more common in older people
In conclusion, Ipamorelin presents a promising avenue for research in fields like anti-aging, injury recovery, and womens health
US$ 26.09
US$ 21.05
US$ 24.07
US$ 21.74
US$ 21.40
